November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
October 27, 2016 — Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole ...
October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compa ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of financing ...
October 17, 2016 — Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that ...
October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the ...
September 27, 2016 — In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the ...
September 1, 2016 — First outcome results from the GLORIA-AF Registry show that treatment with Pradaxa (dabigatran ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
August 30, 2016 — Medtronic plc announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee ...
August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St. Jude ...
August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool ...
August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous ...
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...